AN OROTIC ACID-INDUCED, ADENINE-REVEREED INHIBITION OF HEPATIC LIPOPROTEIN SECRETION IN THE RAT.
D000225:Adenine; D000273:Adipose Tissue; D000963:Antimetabolites; D002784:Cholesterol / Q000097:blood*; D005227:Fatty Acids; D005234:Fatty Liver; D005989:Glycerides; D007422:Intestines; D050356:Lipid Metabolism; D008074:Lipoproteins; D008099:Liver / Q000502:physiology*; D008643:Mesentery; D009963:Orotic Acid; D010600:Pharmacology; D010743:Phospholipids; D051381:Rats; D012106:Research; D013501:Surface-Active Agents; D014316:Tritium
D000963:Antimetabolites; D005227:Fatty Acids; D005989:Glycerides; D008074:Lipoproteins; D010743:Phospholipids; D013501:Surface-Active Agents; D014316:Tritium; D009963:Orotic Acid; D002784:Cholesterol; D000225:Adenine
ADENINE; ADIPOSE TISSUE; ANTIMETABOLITES; BLOOD CHOLESTEROL; CHOLESTEROL; EXPERIMENTAL LAB STUDY; FATTY ACIDS; FATTY LIVER; GLYCERIDES; INTESTINES; LIPID METABOLISM; LIPOPROTEINS; LIVER FUNCTION; MESENTERY; OROTIC ACID; PHARMACOLOGY; PHOSPHOLIPIDS; RATS; SURFACE-ACTIVE AGENTS; TRITIUM